NEUROFIT - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

NEUROFIT

Preclinical Research

WHITE PAPERS

Animal Models of Cognitive Dysfunction

Animal Models of Relapsing-Remitting Multiple Sclerosis

View all Whitepapers

PRODUCTS & SERVICES

Models and Assays

Neurofit Programmes

Research Collaboration

View all Products & Services

LATEST PRESS RELEASES

February 15, 2010

Animal Model of Relapsing-Remitting Multiple Sclerosis: Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in the Rat

Neurofit is pleased to provide the model of Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (RR-EAE) in the rat.

January 15, 2010

New In-Vivo Model of Panic Anxiety Available at Neurofit

Neurofit is pleased to provide the model of Cholecystokinin tetrapeptide (CCK-4) –induced panic anxiety to their potential customers.

View all Press Releases

NEUROFIT

NEUROFIT is a CRO (Contract Research Organisation) specialised in the evaluation of treatments for central (CNS) and peripheral nervous system (PNS) disorders, autoimmune diseases and for Oncology.

Drug screening

NEUROFIT is located near Strasbourg (France) and is part of the Alsace BioValley Network. NEUROFIT offers a long list of validated methods and disease models for drug screening and provides customers with high quality research data and reports. We have an extensive Quality Assurance Program, covering reception of samples through final reporting.

Contact NEUROFIT

Boulevard S颡stien Brant
Bioparc – Parc d’Innovation
67400 Illkirch
France
Tel: +33 (0)3 88 65 16 06
Fax: +33 (0)3 88 65 16 22
Email: neurofit@neurofit.com
Website: www.neurofit.com

Models and Assays

In Vitro Neurofit offers a large range of models and assays for evaluating neurotoxicity, neuroprotection or neurotrophic activity of new test compounds. We can also develop custom protocols to determine mechanism of action, or define therapeutic indication of new drug candidates. Rodent Primary Culture: Cortical, hippocampal, mesencephalon neurons Spinal cord motor neurons Sensory neurons (dissociated…

MORE ABOUT THIS PRODUCT

BROCHURE AVAILABLE

Neurofit Programmes

Compound Neurofit designs screening programmes for specific target indications. According to your target indications we can establish a screening programme for your drug project. In-house expertise allows us to assist you in most central and peripheral nervous system disorders. Phenomouse The Phenomouse programme consists of phenotyping mutant mice by behavioural, histological and biochemical tests. A…

MORE ABOUT THIS PRODUCT

BROCHURE AVAILABLE

Research Collaboration

Work with Neurofit as if it was part of your own organisation: Under a Master Services Agreement a programme can be established where you work directly with the scientist responsible for the testing. This will allow you to rapidly obtain access to already validated screening methods and to draw on our in-house expertise. Data reporting,…

MORE ABOUT THIS PRODUCT

BROCHURE AVAILABLE

Animal Models of Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (RR-EAE) is an animal model that mimics the initial courses of multiple sclerosis in humans. A rat model of RR-EAE is available at Neurofit. This model responds positively to anti-inflammatory / immunosuppressant drugs such as dexamethasone. For more information, please download this free white paper.

DOWNLOAD WHITEPAPER

Animal Models of Cognitive Dysfunction

Three instrumental in-vivo assays for assessing the efficiency of drugs for the treatment of cognitive deficits are available at Neurofit. These assays can also be used to assess the side effect of drugs on memory (safety pharmacology).

DOWNLOAD WHITEPAPER

Contact NEUROFIT

First Name*

Last Name*

Email*

Telephone Number

Role In Purchasing*

Job Title*

Job Function*

Company*

Company Activity*

Country*

Comments

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Address Line 1

Address Line 2

City

County/State

Postcode/ZIP Code

Fax

Company Turnover

No of Employees

Email Updates

Please confirm which of the FREE email services you would like to receive from us, you can unsubscribe at any time:

Pharmaceutical Business review Daily Update

Pharmaceutical Business review Weekly Round-up

magazinePharmaceutical Business review Magazine

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

If you would like to hear from carefully selected third party companies, check this box

Drug Discovery

Research & Development

FDA grants fast track designation for Elevation Oncology’s EO-3021

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

FDA grants priority review for AstraZeneca’s Calquence sNDA

AbbVie seeks FDA approval for non-small cell lung cancer treatment

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer

PCI Pharma announces bottling line expansion at Rockford site

Suppliers

No data found

NEUROFIT

Preclinical Research

Animal Model of Relapsing-Remitting Multiple Sclerosis: Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in the Rat

New In-Vivo Model of Panic Anxiety Available at Neurofit

Drug screening

Contact NEUROFIT

Top Products from NEUROFIT

Models and Assays

Neurofit Programmes

Research Collaboration

Animal Models of Relapsing-Remitting Multiple Sclerosis

Animal Models of Cognitive Dysfunction

Three instrumental in-vivo assays for assessing the efficiency of drugs for the treatment of cognitive deficits are available at Neurofit. These assays can also be used to assess the side effect of drugs on memory (safety pharmacology).

Optional Data

Email Updates

Confirmation